23
Views
3
CrossRef citations to date
0
Altmetric
Review

Primary prevention of epilepsy in patients with different epileptogenic conditions

, &
Pages 945-952 | Published online: 10 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Asla Pitkänen. (2004) On the way to cure epilepsy. Expert Review of Neurotherapeutics 4:6, pages 917-920.
Read now

Articles from other publishers (2)

Miguel Domínguez-Páez, José Luis Herranz-Fernández, Vicente Villanueva-Haba, Juan Carlos Sánchez-Álvarez, Gonzalo Olivares-Granados, Rafael García-de Sola, Julio Albisua-Sánchez, Miguel Ángel Arráez-Sánchez, Bernardo Mosqueira-Centurión, Santiago Amaro-Cendón, Alicia Bollar-Zabala, Fernando Carceller-Benito, Julio Salazar-Hernández, Carlos Fernández-Carballal, Alfredo García-Allut, Eduardo García-Navarrete, Antonio Gutiérrez-Martín, José Luis Lara-Cantalejo, Javier Márquez-Rivas, Bartolomé Oliver-Abadal, I.ñigo Pomposo-Gaztelu, Ángel Prieto-González, Jordi Rumiá-Arboix & Enrique Úrculo-Bareño. (2012) Control de las crisis epilépticas durante el postoperatorio inmediato de los tumores cerebrales supratentoriales: recomendaciones del Grupo de Neurocirugía Funcional y Estereotáctica de la Sociedad Española de Neurocirugía. Neurocirugía 23:1, pages 29-35.
Crossref
TorbjÖrn. Tomson & Bernhard J. Steinhoff. 2012. Epilepsy. Epilepsy 683 698 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.